4.8 Editorial Material

Does the World Still Need New Covid-19 Vaccines?

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 386, 期 22, 页码 2140-2142

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMe2204695

关键词

-

向作者/读者索取更多资源

Although there was a global shortage of Covid-19 vaccines in 2021, by mid 2022, vaccine supply will no longer be a limiting factor in achieving more equitable coverage. Efforts to scale up manufacturing capacity through the COVAX program and other means are projected to meet the World Health Organization's target of vaccinating 70% of the global population by mid 2022.
Although there was a global shortage of Covid-19 vaccines in 2021, by mid 2022, the vaccine supply will no longer be a limiting factor in efforts to provide more equitable coverage. As of April 19, 2022, approximately 11.5 billion Covid-19 vaccine doses have been administered globally.(1) Scaling up manufacturing capacity for currently available vaccines at the speed promised by vaccine producers through the COVAX (Covid-19 Vaccines Global Access) program and beyond should secure the coverage target projected by the World Health Organization (WHO) for 70% of the world population by mid 2022.(2) So why do we still need new Covid-19 . . .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据